Chimeric miRNA cluster enables multiplex and titratable gene inhibition in CAR-T cells

• Reka Agnes Haraszti

Affiliations

Reka Agnes Haraszti

Department of Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany; Gene and RNA Therapy Center (GRTC), Faculty of Medicine, University of Tuebingen, Tuebingen, Germany; Corresponding author: Reka Agnes Haraszti, MD, PD, Department of Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.